Clinical Trials

New Drug Duo Gives Hope for Deadly Pediatric Brain Cancer
Research & Development New Drug Duo Gives Hope for Deadly Pediatric Brain Cancer

In the challenging landscape of pediatric oncology, researchers from St. Jude Children's Research Hospital have illuminated a new path forward with a highly promising combination therapy designed to combat atypical teratoid rhabdoid tumor (ATRT), a rare and exceptionally aggressive form of brain

Urinary MicroRNA Aging Clock – Review
Research & Development Urinary MicroRNA Aging Clock – Review

The longstanding quest to measure the true pace of human aging, independent of the calendar, has taken a decisive turn with the development of a biomarker that can be read from a simple urine sample. The development of the urinary microRNA (uEV-miRNA) aging clock represents a significant

Protein Partnership Reveals a Genetic Cause of Obesity
Research & Development Protein Partnership Reveals a Genetic Cause of Obesity

A comprehensive analysis of a recent study has unveiled the pivotal role of a partner protein in supporting a key appetite-regulating protein, providing profound new insights into the molecular mechanisms governing human energy balance. This discovery, led by an international research team from the

What Connects Energy, Immunity, and ME/CFS?
Tech & Innovation What Connects Energy, Immunity, and ME/CFS?

For millions grappling with an illness that profoundly saps their vitality without a clear biological explanation, the search for answers has been a long and frustrating journey. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has long been an enigma, a constellation of debilitating

AI Model Forecasts Early Prostate Cancer Treatment Response
Research & Development AI Model Forecasts Early Prostate Cancer Treatment Response

A groundbreaking predictive model is set to fundamentally alter how clinicians manage metastatic hormone-sensitive prostate cancer (mHSPC), offering a new beacon of clarity in a field often clouded by uncertainty. This innovative artificial intelligence tool, developed by a team of leading

Blood Test Reveals Who Benefits From Colon Cancer Drug
Research & Development Blood Test Reveals Who Benefits From Colon Cancer Drug

For decades, oncologists have wrestled with a difficult paradox in treating colon cancer: a promising anti-inflammatory drug seemed to work for some patients but not for others, leaving doctors without a clear path forward until a re-examination of old evidence revealed a hidden clue in the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later